StockWatch
·
Q2 FY-2027 RESULTS · TRUALT

TruAlt swings to ₹35 Cr consolidated profit YoY, but margins cool sharply from Q1's high

revenue +606.22% · margins compressing · miss vs street

Q2 FY27 resultsTRUALTTrualt Bioenergy Ltd23 Oct 2026 · 3 min read
Revenue

₹811.1 Cr

+606.22% YoY

PAT (consolidated)

₹34.99 Cr

Net margin

4.25%

+33.5pp YoY

EPS

₹4.04

TruAlt Bioenergy posted a consolidated net profit of ₹34.99 Cr for Q2 FY27 (quarter ended September 30, 2026), reversing a ₹37.94 Cr loss in the year-ago quarter as revenue scaled to ₹811.10 Cr from a thin ₹114.86 Cr base (+606% YoY). Against our pre-result preview — which flagged margin stability as the key swing factor after an "explosive" Q1 where revenue doubled and profit surged 12-fold — the print falls short: PAT of ₹34.99 Cr misses the ₹55-65 Cr band we set out, and EBITDA margin (PBT + finance cost + depreciation, over total income) works out to roughly 14%, below the 20-22% expectation and down from ~21% in Q1 FY27. Net profit margin compressed to 4.25% from 9.24% sequentially, and PAT fell 40.9% quarter-on-quarter from Q1's ₹59.27 Cr even as revenue kept climbing 29.4% QoQ — the topline momentum held, but profitability did not keep pace, the sequential slowdown the preview warned weakness would raise questions on.

The scoreboard

Q2 FY-2027 vs prior quarters

Consolidated P&L, ₹ Crore
Q2 FY-2027QoQYoY
Revenue₹811.1 Cr+29.4%+606.2%
Expenses₹776.65 Cr+38%+334.4%
PAT₹34.99 Cr-40.96%—
Net margin4.25%-5pp+33.5pp
EPS₹4.04-39.4%-24.8%

The margin squeeze sits mainly on the cost lines that scale with the dual-feed/grain ramp: cost of materials consumed and purchases of stock-in-trade together rose faster than revenue quarter-on-quarter, while finance costs also stepped up to ₹42.47 Cr from ₹38.60 Cr in Q1, consistent with the debt-funded capacity build (CBG capex guided at ₹760 Cr, 70:30 debt). Management's prior-quarter guidance covered ethanol order book (44 Cr litres against a 55 Cr-litre capacity target) and Q2 volume (11-12 Cr litres) in physical terms that this P&L filing does not disclose, so volume-based guidance cannot be verified from these figures alone — management gives no explicit guidance reconciliation in this filing, and no separate press release or management commentary was provided alongside the regulatory results.

₹
396.78422.4448.03473.65499.27406.707-2008-1109-0209-2510-2110-23Q2 FY-2027 results
The tape into the print — daily closes, last 3 months

The stock went into the print at ₹406.7, down 1.9% over the past month of trading.

₹ Cr
-50.8-6.5237.7682.054.73Q1 FY26rev ₹304 Cr-37.94Q2 FY26rev ₹115 Cr69.19Q3 FY26rev ₹713 Cr60.95Q4 FY26rev ₹596 Cr59.27Q1 FY27rev ₹627 Cr34.99Q2 FY27rev ₹811 Cr
Quarterly consolidated PAT, ₹ Crore
What management guided (1 FY-2027 call)
FY27: 44 Cr liter ethanol orders on hand (vs 55 Cr capacity target); Q2 sales 11-12 Cr liters expected. CBG: 132 TPD new capacity by Q4 FY27 (₹760 Cr capex, 70:30 debt, 51% ownership JVs). SAF: ₹2,000 Cr capex, FY29 revenue, ₹180-200/liter price, 24-25% margins.

On corporate actions, the Board approved a slump sale of the Unit 5 undertaking to Onkar Agro Sugars & Energy Pvt Ltd for a preliminary ₹171 Cr, with ₹193.83 Cr of related assets now reclassified as "held for sale" on the balance sheet — a capital-structure event with no P&L impact this quarter but relevant to the FY27 ethanol/CBG capacity narrative. Separately, promoter-linked entity Nirani Holdings bought roughly ₹14.66 Cr of shares across three tranches in September while the promoter group pledged a combined 17 lakh shares in the same window — governance datapoints worth flagging alongside the earnings print though they don't move these numbers.

  • W1

    Whether EBITDA margin recovers toward the 20-22% band flagged pre-result, after slipping to ~14% this quarter

  • W2

    Progress and proceeds use from the Unit 5 slump-sale to Onkar Agro Sugars & Energy (₹171 Cr preliminary offer)

  • W3

    FY27 ethanol delivery against the 44 Cr-litre order book cited on the Q1 call — no litre-volume disclosure in this result to verify

No exceptional items in current or year-ago quarter, so raw YoY = underlying YoY. Standalone PAT ₹34.42 Cr and consolidated PAT ₹34.99 Cr diverge <2% (NCI of ₹0.31 Cr for the quarter). Tax figures derived by balancing PBT-PAT, consistent with the current+deferred tax breakup shown. Filing is unaudited, limited-review only (unmodified opinion); Q2 figures are the balancing residual between H1 and Q1 per the auditor's "Other Matter" note.

Informational and educational content only. Not investment advice.